Brief: Portage Biotech Provides Update On Clinical-Stage, Development Programs
31/03/2022 13:46
March 31 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH PROVIDES UPDATE ON CLINICAL-STAGE AND
DEVELOPMENT PROGRAMS
* PORTAGE BIOTECH INC - COMPANY CONTINUES TO WORK TOWARD
MULTIPLE
CLINICAL READOUTS IN 2022
* PORTAGE BIOTECH INC - FUNDED TO LEVERAGE OUR PRODUCT
ENGINE TO
DELIVER ON IMPORTANT CLINICAL MILESTONES THROUGH END OF 2023
Source text for Eikon: ID:nGNXb1Vwy4
Further company coverage: PRTG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsAlpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview
NASDAQ RESUMED AT 10:18 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:13 AM
Brief: Alpha Compute Signs Binding Gpu Contract, Leasing ALPHA-03 Cluster Under Four-Year, $81.7 Million Agreement In Its Missouri Superintelligence Factory
Alpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview